v3.26.3
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2026
Equity [Abstract]  
Schedule of Common Stock Reserved for Future Issuance
Shares of common stock reserved for future issuance related to outstanding equity awards and employee equity incentive plans as of September 30, 2026 were as follows (in thousands):
September 30, 2026
Stock options outstanding146
RSUs (including PRSUs) outstanding8,235
Shares available for future grant under 2014 Equity Incentive Plan (the "2014 Plan")9,504
Shares available for future grant under 2026 Inducement Equity Incentive Plan (the "2026 Inducement Plan")2,083
Shares available for future issuance under ESPP3,256
Total shares of common stock reserved23,224
Schedule of Stock Option Activity
A summary of the Company’s stock option activity during the nine months ended September 30, 2026 is as follows (in thousands, except years and per share data):
Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Contractual
Life
(Years)		Aggregate
Intrinsic
Value
Outstanding as of December 31, 2025390 $51.62 
Options granted— — 
Options exercised(236)14.37 
Options forfeited or expired(8)95.77 
Outstanding as of September 30, 2026146 109.10 2.4$153 
Vested and expected to vest as of September 30, 2026146 109.10 2.4153 
Exercisable as of September 30, 2026146 109.10 2.4153 
Schedule of RSU Activity
A summary of the Company’s restricted stock unit ("RSU") activity, including PRSUs, during the nine months ended September 30, 2026 is as follows (in thousands, except per share data):     
Number of SharesWeighted Average Grant Date Fair Value Per Share
Outstanding as of December 31, 20256,029 $43.50 
RSUs granted(1)
5,831 21.44 
RSUs vested and released(2,175)40.16 
RSUs forfeited or cancelled(1,450)40.64 
Outstanding as of September 30, 20268,235 29.27 
(1) Includes 1,304,592 PRSUs granted during the nine months ended September 30, 2026.
Schedule of Stock-based Compensation Expense
Stock-based compensation expense was as follows (in thousands):
Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Cost of revenue$5,690 $6,852 $17,791 $21,332 
Research and development6,297 6,896 21,069 24,415 
Sales and marketing8,339 8,401 25,571 33,330 
General and administrative14,601 11,190 36,140 35,366 
Total stock-based compensation expense$34,927 $33,339 $100,571 $114,443 
Schedule of Unrecognized Compensation Expense
As of September 30, 2026, unrecognized stock-based compensation expense by award type and expected weighted-average recognition periods are summarized in the following table (in thousands, except years).
Stock OptionRSU
(excluding PRSUs)		PRSUESPP
Unrecognized stock-based compensation expense$— $179,577 $30,777 $450 
Weighted-average amortization period0.0 years2.1 years1.8 years0.1 years
Schedule of Valuation Assumptions, Stock Option
The weighted-average assumptions used to value PRSUs with market conditions granted during the periods presented were as follows:
PRSUs (Market Conditions)
Three Months EndedNine Months Ended
September 30, 2026September 30, 2025September 30, 2026September 30, 2025
Expected term (years)2.52.42.82.8
Volatility64.6 %52.2 %60.6 %55.2 %
Risk-free interest rate4.2 %3.7 %3.6 %4.0 %
Dividend yield (1)— — — — 
(1)The Company has not paid, and does not anticipate paying, cash dividends on its shares of common stock. Accordingly, the expected dividend yield is zero.